Meridian Bioscience Announces New Board Member - Anthony Bihl
“We welcome Tony to the board as a new independent director and look forward to the leadership he will bring,” said
Bihl graduated with distinction from
“Meridian was an early pioneer in gastrointestinal diagnostics and has stayed true to those roots,” said Bihl. “I have been following their turnaround under Jack Kenny’s leadership and look forward to working with him and the rest of the board as the growth story continues.”
For more information on Meridian, please visit www.meridianbioscience.com.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.
Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.
Vice President – Investor Relations
Phone: +1 513.271.3700
Source: Meridian Bioscience Inc.